Top

Pediatric Drugs

Published in:

01-10-2002 | Guest Commentary

Lamivudine

A Viewpoint by Nicholas C. Tassopoulos

Author: Nicholas C. Tassopoulos

Published in: Pediatric Drugs | Issue 10/2002

Excerpt

Chronic hepatitis B is one of the most common and serious infectious diseases worldwide. Current global estimates suggest that 350 million people have chronic hepatitis B virus (HBV) infection and 25 to 40% of these will develop cirrhosis, liver failure or hepatocellular carcinoma. HBV is mainly spread by perinatal transmission in areas with high prevalence (>7%) and by horizontal transmission during early childhood in areas with an intermediate prevalence (2 to 7%). …

Title: Lamivudine
A Viewpoint by Nicholas C. Tassopoulos
Author: Nicholas C. Tassopoulos
Publication date: 01-10-2002
Publisher: Springer International Publishing
Published in: Pediatric Drugs / Issue 10/2002
Print ISSN: 1174-5878
Electronic ISSN: 1179-2019
DOI: https://doi.org/10.2165/00128072-200204100-00006

At a glance: The STEP trials

Springer Medicine

Lamivudine

A Viewpoint by Nicholas C. Tassopoulos

Excerpt

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 10/2002

Gastroesophageal Reflux in Children

Lamivudine

An Approach to the Treatment of Pediatric Myocarditis

Measles, Mumps and Rubella Vaccine, Autism and Inflammatory Bowel Disease

Benefit and Risks of Local Anesthetics in Infants and Children

Lamivudine